Hairmax

Actonis Hair & Scalp Dual Action Nutraceutical

Miglior prezzo disponibile
65,00$
eCosmetics
Vedi Offerta
Prezzi aggiornati · 1 offerte confrontate

Confronto prezzi

1 offerte disponibili
eCosmeticsMiglior prezzo
In stock · Nuovo
65,00$

Storico prezzi

Ricevi una notifica se il prezzo scende

Ti invieremo un'email quando il prezzo di questo prodotto diminuirà.

  • Aggiornamenti dei prezzi in tempo reale
  • Oltre 50 negozi monitorati
  • Avvisi gratuiti di calo prezzo
  • Solo negozi verificati

Avvisami quando il prezzo scende sotto: 65,00$

Ho letto e accettato i informativa sulla privacy.
Specifiche
MarcaHairmax
CondizioneNuovo
Descrizione
eCosmetics is an authorized retailer of Hairmax. Introducing Actonis TM Hair & Scalp Nutraceuticals, the ultimate hair growth supplement designed to provide optimal nutrition for every stage of your hair cycle, Anagen Growth phase, Catagen Transition phase and Telogen Shedding phase.This powerhouse formula providesu202fessential minerals to help regulate hair growth cycles and encourage healthy hair growth.u202f Formulated by hair growth experts, Actonis TM contains clinically proven ingredients like, Lustriva TM + 10,000mcg of Biotin, a cutting-edge and highly absorbable form of biotin, silicon, and magnesium biotinate. LustrivaTM boasts a remarkable 40 times greater biotin solubility than standard D-biotin.In a clinical studyu202fLustriva TMu202fincreased hair growth in as little as 3 weeks and hair thickness in 12u202fweeks vs. placebo*u202fu200bIn addition, our proprietary Actonis Botanical Blend formula contains dual action DHT blockers, Saw Palmetto and Prickly Pear, combined with the enriching properties of Curcumin and Ashwagandha, creating an unparalleled synergy for optimal hair health.Elevate your hair care routine with Actonis u2013 and witness the transformation to a head of hair that radiates vitality, strength, and undeniable beauty.100% drug free. Made in the USATry it today for fuller, thicker hair in just 3 weeks+.*in a pre-clinical study +compared to baseline in a clinical study using Lustriva ™